Anti-SARS-CoV-2 (COVID-19) NSP7 antibody produced in rabbit

rabbit

100

unconjugated

affinity isolated antibody

primary antibodies

polyclonal

liquid

SARS coronavirus

1 mg/mL

ELISA: suitable
immunohistochemistry: suitable

IgG

YP_009742614.1

P0DTC1

wet ice

−20℃

SARS coronavirus ... ORF1ab(43740578)

Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak. The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP7 plays a role in viral RNA synthesis (3,4,5). It forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers.

Anti-SARS-CoV-2 (COVID-19) NSP7 antibody was raised against a peptide corresponding to 12 amino acids near the carboxyl terminus of the SARS-CoV-2 (COVID-19) NSP7 protein. The immunogen is located within the last 50 amino acids of the SARS-CoV-2 (COVID-19) NSP7 protein.

Antibody validated: Immunohistochemistry in human samples. SARS-CoV-2 (COVID-19) NSP7 antibody can detect 2 ng of free peptide at 1 μg/mL in ELISA. It can detect SARS-CoV-2 NSP7 recombinant protein by ELISA. All other applications and species not yet tested.

Supplied in PBS containing 0.02% sodium azide.

12 - Non Combustible Liquids

nwg